Patents by Inventor Noubar Boghos Afeyan

Noubar Boghos Afeyan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090203070
    Abstract: The present disclosure identifies pathways and mechanisms to confer improved industrial fitness on engineered organisms. It also discloses engineered organisms having improved industrial fitness. Synthetic biologic engineering modules are disclosed that provide for light capture, carbon dioxide fixation, NADH production, NADPH production, thermotolerance, pH tolerance, flue gas tolerance, salt tolerance, nutrient independence and near infrared absorbance. The disclosed engineered organisms can include one or more of these modules. Also provided are methods of using the engineered organism to produce carbon-based products of interest, biomass or pharmaceutical agents.
    Type: Application
    Filed: November 10, 2008
    Publication date: August 13, 2009
    Applicant: JOULE BIOTECHNOLOGIES, INC.
    Inventors: Eric James Devroe, Sriram Kosuri, David Arthur Berry, Noubar Boghos Afeyan, Frank Anthony Skraly, Dan Eric Robertson, Brian Green, Christian Perry Ridley
  • Publication number: 20090191599
    Abstract: The present disclosure identifies pathways and mechanisms to confer photoautotrophic properties to a heterotrophic organism. The resultant engineered cell or organism will uniquely enable efficient conversion of carbon dioxide and light into biomass and carbon-based products of interest.
    Type: Application
    Filed: September 10, 2008
    Publication date: July 30, 2009
    Applicant: Joule Biotechnologies, Inc.
    Inventors: Eric James Devroe, David Arthur Berry, Noubar Boghos Afeyan, Dan Eric Robertson, Frank Anthony Skraly, Christian Perry Ridley
  • Publication number: 20090047295
    Abstract: The invention provides methods and compositions for reducing the number of cancer stem cells in a mixed population of differentiated cells (for example, cancer cells) and cancer stem cells. The cancer stem cells, if present, can be more resistant to traditional drug-based therapies and can provide a source for new, differentiated cancer cells associated with the development of drug-resistance and more aggressive phenotypes. When combined with traditional cancer therapies, for example, drug-based therapies, the methods and compositions of the invention provide a more effective way for treating cancer and can provide a model system for developing new cancer therapies and new treatment modalities.
    Type: Application
    Filed: July 11, 2008
    Publication date: February 19, 2009
    Inventors: David A. Berry, Eric J. Devroe, Noubar Boghos Afeyan, Brett Chevalier, Sashank K. Reddy
  • Publication number: 20020192721
    Abstract: The present invention provides Modular Molecular Clasps and methods of using these Modular Molecular Clasps in a wide range of applications in the health care industry, e.g., in therapy, in clinical diagnostics, in in vivo imaging or in drug discovery. The Modular Molecular Clasps of the present invention also have industrial and environmental applications, e.g., in environmental diagnostics, industrial diagnostics, food safety, toxicology, catalysis of reactions or high-throughput screening; as well as applications in the agricultural industry and in basic research. Methods of designing the Modular Molecular Clasps, as well as arrays and biosensors comprising these Modular Molecular Clasps are also provided.
    Type: Application
    Filed: November 28, 2001
    Publication date: December 19, 2002
    Applicant: engeneOS, Inc.
    Inventors: Carlo Dante Rizzuto, Noubar Boghos Afeyan, Frank Don Lee, George McDonald Church, Ruchira Das Gupta, John Jacob Schwartz, Bin Zhang, Alexey Alexandrovich Lugovskoy